Representative Melissa Minor-Brown’s House Bill 141, which would add a condition called “New Daily Persistent Headache (NDPH)” to the list of conditions eligible for treatment with medical marijuana, has been released from committee and is ready for a vote on the House floor as of yesterday.
New daily persistent headache (NDPH) is a rare headache disorder characterized by daily and unremitting headaches that can last up to 3 days, much like migraine headaches. The headache onset is abrupt and the throbbing, pressure-like pain is usually on both sides of the head. In order to be diagnosed with this syndrome, a patient must have chronic daily headaches that are present more than 15 days a month for more than 3 months. The age of onset ranges from 6 to greater than 70 years old. It is found to be more common in females in both the adult and pediatric populations.
Currently, there is no specific treatment for NDPH. Instead, most are treated similarly to migraines with prescriptions to opiates or narcotics such as gabapentin. In order to avoid the development of medication overuse or opioid addiction, however, physicians do not advise patients to use pain relievers for more than 9 days a month even though the pain persists for many days more than that.
This bill adds new daily persistent headache and chronic debilitating migraines to the list of chronic or debilitating medical conditions for which a child under 18 may qualify as a patient to receive marijuana oil upon certification by a physician in accordance with the terms of the Delaware Medical Marijuana Act. This bill also adds new daily persistent headache to the list of chronic or debilitating medical conditions that qualifies an adult to be eligible for the use of medical marijuana.
WHERE IS THE BILL? House Health & Human Development 5/6/19
DEMOCRATIC SPONSORS – Minor-Brown, McBride, Lopez, Schwartzkopf
REPUBLICAN SPONSORS –
YES VOTES –
NO VOTES –